It will all end in multi-tiers!
In reflective mood, Nostrapharmus muses on developments in health and safety and, with the explosion of outsourcing, what the landscape could look like in ten years' time
Nostrapharmus may be all about predicting the future, but let's begin by casting our minds back 30-40 years. Those of you who have held line management positions during those years can probably still remember what the Health and Safety regulatory environment was like, or not, as the case may be. The compulsory use of Personal Safety Equipment was creeping into the regulation. Managers spent many hours and disciplinary meetings with employees to convince, persuade, or force the use of safety shoes, glasses, and noise protection. Moving forward a little in time; the Seveso disaster of 1976 was most tragic and left a never fading impression on the people that lived there, and survived this catastrophe. The impact on us, the pharma industry, was enormous. New legislation and regulations were introduced in response. Again, line managers often struggled to get their employees to adhere to the new rules. Other examples like the Thalidomide tragedy, and the Devonport Hospital disaster were pivotal in moulding today's regulatory environment. Each incident driving new legislation that bit further to defining the way in which pharmaceuticals should be both manufactured and released.
If you would like to read this article in full, please click on the pdf link below:
It will all end in multi-tiers!
or to view the magazine, follow the link below, the article can be found on pages 64-65:
http://viewer.zmags.com/publication/2f37a868#/2f37a868/65
About Pharma magazine
Aimed at the international pharmaceutical and bio-pharmaceutical community, Pharma magazine covers every aspect of manufacturing from R&D to finished product. With a worldwide circulation of more than 40,000 individuals it is the first truly global magazine for the pharma industry, bringing together the disciplines of discovery and development, the drug manufacturing process and the resultant business and management issues.For further information visit the Pharma magazine website www.pharma-mag.com